-
Largest Cannabis Co. Curaleaf's $1.5B Projected Revenue For 2025: Analyst Raises Rating To Outperform
Tuesday, May 14, 2024 - 5:32pm | 621Wedbush Securities released a report on Curaleaf Holdings, Inc. (OTC: CURLF), the largest U.S. cannabis company by market cap, raising the stock's 12-month price target to $7.00 from $6.00 and maintaining a buy recommendation (Outperform rating). Key Financials And Rating Curaleaf's market...
-
Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%
Monday, April 15, 2024 - 7:53pm | 948Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector. The Viridian Cannabis Deal Tracker has become an indispensable tool for companies, investors and acquirers in the cannabis...
-
Green Thumb Industries' $278M Profits, Margin And Strategic Insights Explained For Everyday Investors
Wednesday, February 28, 2024 - 7:09pm | 842Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF) reported its earnings late Wednesday, revealing significant financial achievements for the fourth quarter and full year ended December 31, 2023, including increased profits, enhanced margins and an adjusted EBITDA of $326 million. Key...
-
EBITDA Growth And Multi-State Opportunities In Key States Going Legal: Zuanic & Associates' Insights
Tuesday, November 21, 2023 - 7:57pm | 653Zuanic & Associates' latest report offers a thorough analysis of the financial impacts expected in key U.S. states, including Florida, Minnesota, Ohio, Pennsylvania and Virginia, as they move toward recreational cannabis sales by 2025. Highlighting both EBITDA and market cap upside,...
-
Cannabis Chart Of The Week: Q2 EBITDAs Beat Estimates, But Full-Year Projections Tell A Different Story
Monday, August 21, 2023 - 3:10pm | 801Second quarter 2023 earnings releases are complete, and the results were fascinating. One of the things that makes us skeptical about these quarterly reports is the forceful steering that companies apply to try to move estimates down. We generally lay out the earnings schedule weeks in...
-
Cannabis Chart Of The Week: What SHOULD EBITDA Multiples Be?
Monday, August 14, 2023 - 12:37pm | 746We created a discounted cash flow model ("DCF") to calculate a range of theoretically supportable EV/EBITDA multiples, given analysts' expectations for 2022-2024 and reasonable assumptions for the seven years after that. We based our model on a hypothetical $1 of EBITDA and generated...
-
Cannabis Chart of the Week: How Aggressive Are 2nd Quarter EBITDA Margin Estimates?
Monday, July 31, 2023 - 2:07pm | 820The chart shows analyst estimates of EBITDA margins for the second quarter vs. the first quarter and the 2nd quarter of 2022 for the fourteen largest MSOs for which we have consistent analyst projections. The blue bars show Q1 23 EBITDA margins; the red bars show Q2: 23 projected EBITDA...
-
What U-Haul Earnings Are Showing, Heading Up?
Thursday, June 1, 2023 - 5:04pm | 891The world of work and real estate is changing as consumers and investors know it, with remote or mostly remote work making up to 34% of the total American workforce and rent inflation reaching rates as high as 6.9% for the year 2022. As more workers fulfill their duties on a...
-
Cannabis Chart Of The Week: Pushing The Limits Of Debt Financing, Time For Investors To Be Careful
Tuesday, May 30, 2023 - 1:50pm | 983Aggregate net debt to LTM EBITDA for the top MSOs is now 3.0x with five of the eleven over 5x, arguably unsustainable in a 280e world. The graph shows two essential indicators of cannabis company leverage and credit quality: Net debt/ LTM EBITDA and Net Debt/ Enterprise Value. The chart depicts...
-
Earnings Roundup: Neptune, Item9, GW Pharmaceuticals
Tuesday, February 16, 2021 - 1:31pm | 773Neptune Revenue Declines 63% YoY, Shifts To CPG And Branded Products Global health and wellness company Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) revealed Monday its third-quarter financial results, on the heels of announcing the purchase of a 50.1% stake in baby food and...
-
Supreme Cannabis Reports Q2 Revenue Growth, Posts Adjusted EBITDA Of $3.6M
Friday, February 12, 2021 - 12:59pm | 285The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) has generated roughly $21.7 in gross revenue and $18.3 million in net revenue in the second quarter of fiscal 2021. Over the same period, recreational net revenue increased 70% to $12.7 million. Wholesale net revenue, including...
-
Earnings Roundup: C21 Investments, Body And Mind, CBD Of Denver
Wednesday, December 16, 2020 - 5:34pm | 595Body And Mind Q4 Revenue Increases By 106% Sequentially Cannabis company Body and Mind Inc. (CSE: BAMM) (OTCQB: BMMJ) announced fiscal results for the fourth quarter and fiscal year ending July 31. The Vancouver-based company generated $6.23 million in consolidated revenue for the whole year...
-
Fire & Flower Revenue Spikes 142% YoY On Heels Of Buying Spree
Tuesday, December 15, 2020 - 2:10pm | 380Throughout the third quarter, cannabis retailer Fire & Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWF) found itself on the hunt for acquisition targets. According to the company's most recent earnings statement, the strategy paid off. Fire & Flower generated around $33.1...
-
Earnings Roundup: iAnthus, Can-Fite, Organigram, Bluma Wellness, Auxly
Monday, November 30, 2020 - 1:39pm | 1022iAnthus Touts 82% YoY Revenue Growth, Names Interim COO New York-based iAnthus Capital Holdings Inc. (CSE: IAN) (PINK: ITHUF) generated around $40.6 million in revenue during the third quarter of fiscal 2020. That's up by 17% sequentially and roughly 82% year-over-year. The...
-
Jushi Touts 67% Revenue Increase On Heels Of Pennsylvania Expansion
Tuesday, November 24, 2020 - 2:33pm | 464Cannabis company Jushi Holdings Inc. (CSE: JUSH) (OTCQB: JUSHF) reported Tuesday its third-quarter revenue totaled $24.9 million, up by 67% over the quarter. The revenue increase could be attributed to the revenue growth at its BEYOND/HELLO stores in Illinois and Pennsylvania, as well as...